Mapping the β-Sheet Structure of the Yeast Prion Sup35 through Creation of Targeted Mutant Forms
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Proteins are made based on a DNA sequence template and fold
into distinctive shapes or conformations. Amyloids are proteins
that can fold into a normal form and an abnormal form. Prions
are infectious amyloids that can further cause normally-folded
versions to assume the amyloid shape. Prions are present in
many eukaryotes including humans, cows, sheep, and the
baker’s yeast, Saccharomyces cerevisiae, among other
species. Yeast has several prion proteins including Ure3 and
Sup35, the focus of this study. Yeast prions are usually Q and N
rich and like all amyloids, are composed of β-sheets. It has been
long appreciated that the Sup35 protein in yeast has substantial
β-sheet structure in its N terminal “prion domain” when in its
amyloid form. However, the exact dimensions or interactions of
the β-strands within the β-sheets are poorly
understood. Furthermore, there are few hydrophobic and
charged amino acids residues in this region. In this study we are
testing the effect of adding one lysine amino acid (a charged
amino acid) at several sites in Sup35 on the likelihood of prion
formation and stability, with the goal of helping to map β-sheet
formation in the S. cerevisiae Sup35 prion protein.

HOW DO WE DETECT PRIONS?

Figure 1. From left to right, 500 base pair ladder, construct 20,
construct 25. This is the final PCR before transformation.
The lower bands of construct 20 and 25 were cut out, purified and
used in the transformation process.
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Figure 2. Yeast with a successful transformation of
construct 25 plated on a sc-leu plate. Colonies from
this and the other plates were picked, pre-amplified by
PCR in the SUP35 gene region, and were sent off to
be sequenced.
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CREATING MUTANT VERSIONS OF THE SUP35 PRION GENE
To study effects of mutation on β-sheet formation in the Sup35 protein, experiments
were conducted in a strain of yeast expressing a “super-prion-forming” SUP35 gene.
This SUP35 variant was subjected to 3 additional point mutations within the prion
forming domain, adding the charged amino acid Lysine (K) at three distinct locations.

PRIONS ARE INFECTIOUS AMYLOIDS

PCR-based mutagenesis was employed to generate a full-length “2-piece” PCR product
encoding mutated versions of the
E prion domain of SUP35.
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None of the selected yeast colonies sequenced contained the
intended lysine insertions; however, different colonies from the
same yeast plates could be correct and should be evaluated.
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If those yeast colonies do have the mutation we could then use
those colonies to assess the different properties each mutation
has on prion properties of the Sup35 protein. We intend to create
versions with multiple insertions as well.
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Figure 3. Representative DNA sequencing results from a single white colony from
construct 25. The red arrow indicates where the sequence for the Sup35 gene begins,
indicating the plasmid was successfully integrated into the SUP35 gene. However,
despite the successful transformation, none of the yeast constructs sequenced
contained the intended mutation in their given sites.
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These mutant PCR products were transformed into a prion-negative yeast strain and
colonies were selected on the basis of nutritional markers (LEU2). PCR was employed
to amplify the SUP35 gene from each clone, followed by DNA sequencing by Genewiz,
Inc. (New Jersey).
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Introduced mutations were
designed to hit at different
points (residue 15, 20, 25) in the
β-strands and potentially have
greater/lesser effects on prion
structure, stability, etc.

If we do not find any colonies with the indicated mutations we
could either start over making the mutants or design lysine
insertions in different locations. Similarly we could try making
constructs with an amino acid other than lysine. For example, we
have already acquired reagents to introduce prolines, which are
known to break β-sheet structures.
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